The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has been reconfigured to transform it into a truly global initiative with robust and transparent governance mechanisms.

The ICH will promote public health through international harmonisation of technical requirements for the authorisation and regulatory oversight of medicinal products. This will help with the timely introduction of new medicines, the prevention of unnecessary duplication of clinical trials, and the development, registration and manufacture of safe, effective and high quality medicines in an efficient and cost-effective manner.

For more information about the changes to the ICH, click here on the website